Find clinical trials for Breast Cancer in Kansas City, KS
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Breast Cancer trials near Kansas City, KS, USA:
Study combination use of cisplatin plus romidepsin and nivolumab in metastatic triple negative breast cancer (TNBC) or BRCA mutatio ...
Phase 1, Phase 2
Kansas City, Kansas, United States and 6 other locations
growth factor receptor-2 negative (HER2-) advanced/metastatic breast cancer who received no prior cyclin-dependent kinase targeting...
Phase 2
Merriam, Kansas, United States and 33 other locations
Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...
Phase 3
Kansas City, Kansas, United States and 76 other locations
The standard treatment for women with stage I, II, and III triple-negative breast cancer (TNBC) includes chemotherapy and surgery, ...
Phase 2
Kansas City, Kansas, United States and 8 other locations
postmenopausal women with locally advanced or metastatic ER+/HER2- breast cancer with an acquired ESR1 mutation and who have diseas...
Phase 2
Kansas City, Missouri, United States and 50 other locations
This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...
Phase 3
Kansas City, Missouri, United States and 226 other locations
A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....
Phase 3
Kansas City, Missouri, United States and 318 other locations
with pathology-confirmed HR-positive/HER2-negative metastatic breast cancer (MBC) following progression on or after at least two pr...
Phase 2
Kansas City, Missouri, United States and 51 other locations
The purpose of this study will be to evaluate, in a multi-center setting, the ability of radiofrequency ablation (RFA) of breast cancer...
Westwood, Kansas, United States and 5 other locations
This is a first-in-human study of MEN2312, a lysine acetyltransferase 6 (KAT6) inhibitor, in adult participants with advanced breast cancer...
Phase 1
Westwood, Kansas, United States and 38 other locations
Clinical trials
Research sites
Resources
Legal